Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of treat cutaneous T-cell lymphoma; and SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of …
Over the last 12 months, insiders at Soligenix, Inc. have bought $0 and sold $0 worth of Soligenix, Inc. stock.
On average, over the past 5 years, insiders at Soligenix, Inc. have bought $17,899 and sold $2,701 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 20,000 shares for transaction amount of $8,866 was made by SCHABER CHRISTOPHER J (CHAIRMAN, CEO AND PRESIDENT) on 2022‑05‑18.
2022-05-18 | SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 20,000 0.0466% | $0.44 | $8,866 | +23.81% | ||
2022-05-18 | Straube Richard | SENIOR VICE PRESIDENT AND CMO | 8,000 0.021% | $0.50 | $4,000 | +23.81% | ||
2021-12-17 | SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 7,000 <0.0001% | $0.74 | $5,179 | -13.05% | ||
2021-12-15 | Guarino Jonathan L. | Senior Vice President and CFO | 1,000 <0.0001% | $0.70 | $700 | -10.86% | ||
2021-12-14 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 10,000 0.0001% | $0.73 | $7,269 | -7.05% | ||
2021-12-14 | Guarino Jonathan L. | Senior Vice President and CFO | 10,000 0.0001% | $0.71 | $7,119 | -7.05% | ||
2021-05-14 | Sale | ZELDIS JEROME B | director | 3,000 <0.0001% | $0.90 | $2,701 | +1.43% | |
2021-05-14 | ZELDIS JEROME B | director | 3,000 <0.0001% | $0.89 | $2,664 | +1.43% | ||
2019-11-19 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 10,770 0.0544% | $0.93 | $10,016 | +92.63% | ||
2019-11-19 | ZELDIS JEROME B | director | 2,000 0.0101% | $0.93 | $1,850 | +92.63% | ||
2019-09-23 | Parks Diane L. | director | 14,940 0.0003% | $0.93 | $13,870 | +95.33% | ||
2019-09-19 | ZELDIS JEROME B | director | 4,000 <0.0001% | $0.94 | $3,740 | +93.21% | ||
2019-04-22 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 5,000 0.0001% | $0.72 | $3,577 | +47.89% | ||
2019-04-22 | ZELDIS JEROME B | director | 10,000 0.0002% | $0.73 | $7,274 | +47.89% | ||
2018-10-18 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 8,700 0.0002% | $1.17 | $10,177 | -22.88% | ||
2018-10-17 | Pearson Mark E. | director | 170,000 0.0046% | $1.16 | $197,200 | -13.90% | ||
2018-08-22 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 3,530 <0.0001% | $1.42 | $5,012 | -30.71% | ||
2017-11-29 | Sale | Essetifin SPA | 16,416 0.0012% | $2.12 | $34,802 | -19.31% | ||
2017-11-29 | Essetifin SPA | 293,510 0.0223% | $2.12 | $622,241 | -19.31% | |||
2017-05-08 | Sale | KIRK RANDAL J | 10 percent owner | 11,576 0.0009% | $2.54 | $29,403 | -16.86% |
CAVAZZA PAOLO | 10 percent owner | 54227816 2160.9012% | $124.72M | 3 | 0 | |
CAVAZZA CLAUDIO | 10 percent owner | 54227816 2160.9012% | $124.72M | 3 | 0 | |
BAM Management LLC | 10 percent owner | 21766092 867.3478% | $50.06M | 1 | 1 | |
Pearson Mark E. | director | 2500000 99.6214% | $5.75M | 1 | 0 | |
KANZER STEVE H | director | 1282203 51.094% | $2.95M | 1 | 0 |
$18,881,323 | 88 | -48.96% | $4.47M | |
$296,936 | 37 | -18.12% | $4M | |
$523,320 | 24 | 94.37% | $7.01M | |
$31,129 | 22 | -11.96% | $6.19M | |
$51,865 | 17 | -38.70% | $6.16M |
Increased Positions | 7 | +116.67% | 11,648 | +17.62% |
Decreased Positions | 2 | -33.33% | 47,192 | -71.39% |
New Positions | 4 | New | 326 | New |
Sold Out Positions | 2 | Sold Out | 47,192 | Sold Out |
Total Postitions | 11 | +83.33% | 30,557 | -53.77% |
Geode Capital Management, Llc | $60.00 | 0.87% | 26,094 | +7,729 | +42.09% | 2024-12-31 |
Morgan Stanley | $9.00 | 0.13% | 3,816 | +3,592 | +1,603.57% | 2024-12-31 |
Ubs Group Ag | $1.00 | 0.01% | 313 | +313 | New | 2024-12-31 |
Plante Moran Financial Advisors, Llc | $1.00 | 0.01% | 300 | 0 | 0% | 2024-12-31 |
Bank Of America Corp /De/ | $0 | <0.01% | 20 | +<1 | +5.26% | 2024-12-31 |
Jones Financial Companies Lllp | $0 | 0% | 10 | +10 | New | 2024-12-31 |
Sbi Securities Co., Ltd. | $0 | 0% | 2 | +2 | New | 2024-12-31 |
Cwm, Llc | $0 | 0% | 1 | +<1 | New | 2024-12-31 |
Albion Financial Group /Ut | $0 | 0% | 1 | 0 | 0% | 2024-12-31 |
Stephens Inc /Ar/ | $0 | 0% | 0 | -46,262 | Sold Out | 2024-12-31 |